港股午評:恆科指大漲6.81% 恆指收復18000點 科技股集體走強
格隆匯11月15日丨港股上午盤三大指數呈單邊上漲行情,恆生科技指數一馬當先,午間大幅收漲6.81%,恆指、國指分別漲3.62%和4.27%,恆指重上18000點大關。盤面上,大型科技股集體拉昇上揚,快手漲約13%,阿里巴巴漲超10%,騰訊漲超9%,美團、百度、京東皆大漲;昨日大漲的內房股與物管股繼續上漲,但個別股票下跌明顯,昨日一度飆漲50%的碧桂園跌超8%;短視頻概念股漲勢最佳,澳門新賭牌主須投資逾千億澳元,濠賭股拉昇明顯,餐飲股、手遊股、蘋果概念股、汽車股等全線走強。另一方面,近期活躍的藥品類股高開低走,開拓藥業、白雲山等紛紛回調。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.